corporate-venture
(2)Angèle Maki
Angèle Maki, PhD, is a biopharmaceutical business development executive with more than 20 years of deal-making across emerging biotechs and global pharma. In December 2025 she became the first Chief Business Officer of Ability Biotherapeutics, a Montreal-based company building logic-gated antibodies with its generative-AI platform AbiLeap. A Stanford-trained biological chemist who started at the University of Winnipeg, she has held senior roles at Medarex, Bristol Myers Squibb, Genentech, 23andMe, Merck, Eli Lilly, ReCode Therapeutics and Callio Therapeutics, and chairs the non-profit Canadian Entrepreneurs in Life Sciences.
Varun Jain
Varun Jain is a Founding General Partner at SE Ventures, the $1.1B AUM corporate venture capital fund backed by Schneider Electric, where he has spent over a decade investing in AI-led enterprise software startups transforming industry, mobility, and the built environment. Before SE Ventures, he led Qualcomm Ventures' global early-stage practice, backing over 80 companies including Zoom, Cruise Automation, and Matterport. A Kellogg MBA and McCormick Scholar, Jain was named one of GCV's Top 50 Emerging Leaders in both 2021 and 2022.